CC Financials

Income Statement
MetricQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025
Revenue
1.5B
-3.2%
1.6B
+15.2%
1.4B
+3.8%
1.3B
-11.0%
1.5B
Cost of Revenue
1.3B
+0.3%
1.3B
+11.6%
1.2B
-0.4%
1.2B
-7.0%
1.3B
Gross Profit
231.0M
-19.2%
286.0M
+34.9%
212.0M
+35.9%
156.0M
-33.0%
233.0M
Operating Expenses
2.0M
-99.6%
499.0M
+168.3%
186.0M
+15.5%
161.0M
+5.9%
152.0M
R&D
24.0M
-11.1%
27.0M
+3.8%
26.0M
-3.7%
27.0M
+3.8%
26.0M
SG&A
-25000000
-105.3%
469.0M
+219.0%
147.0M
+13.1%
130.0M
+6.6%
122.0M
Operating Income
229.0M
+207.5%
-213000000
-919.2%
26.0M
+620.0%
-5000000
-106.2%
81.0M
EBITDA
312.0M
+340.0%
-130000000
-210.2%
118.0M
+47.5%
80.0M
-51.2%
164.0M
Net Income
196.0M
+171.5%
-274000000
-844.8%
-29000000
+53.2%
-62000000
-234.8%
46.0M
EPS (Basic)
$1.29
+171.3%
$-1.81
-852.6%
$-0.19
+53.7%
$-0.41
-232.3%
$0.31
EPS (Diluted)
$1.29
+171.3%
$-1.81
-852.6%
$-0.19
+53.7%
$-0.41
-232.3%
$0.31
Shares (Diluted)
151.9M
+0.5%
151.2M
+0.3%
150.8M
+0.5%
150.0M
-0.5%
150.8M
The Chemours (CC) — Financials